Wednesday starts with Admiral William McRaven and wraps with a fireside chat with FDA Commissioner Robert Califf, always an interesting speaker and an important figure to hear from. In between we’ll feature sessions on AI in drug discovery and obesity therapeutics. Check it all out below.
Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
In this podcast episode, Jesse Mendelsohn and Nicole Raleigh discuss what the future might hold for pharma under a second Trump Administration
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
9th Liquid Biopsy for Precision Oncology Summit | February 18-20, 2025 | San Diego, CA | FREE* to Attend for Biopharma
The pivotal shift in biopharma priorities is steering towards enhancing sustainability measures for drug development.
